Royalty Pharma Reports Third Quarter 2022 Results
Go back to Royalty Pharma Reports Third Quarter 2022 Results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 59.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.69 | 52 Week High | $3.48 | |||
| Open | $59.69 | 52 Week Low | $0.80 | |||
| Day High | $59.69 | P/E | N/A | |||
| Day Low | $59.69 | EPS | $-1.54 | |||
| Volume | 1,076 | |||||
